Management plans to file for regulatory approval of "Tresmi" for PAH and ILD this year, with commercial launch targeted for next year. Tyvaso DPI platform enhancement -- Introduction of 80-microgram ...
The Harvard Kennedy School provides a new AI risk framework worthy of attention. I discuss AI risk management and touch on ...
Researchers are increasingly sounding the alarm that artificial intelligence could end humanity. But such doomsday warnings ...
A writer and researcher whose work highlights Black history and a Kitchener project that’s transformed a century-old ...
Vivendi also holds a stake in Publishing and Travel Retail with Lagardère. And another in the press sector with Prisma Group both with a stake of around 14%. In addition to these holdings, there are ...